Allantaz, F.
15  Ergebnisse:
Personensuche X
?
 
?
4

A point-prevalence study on community and inpatient Clostri..:

Viprey, VF ; Davis, GL ; Benson, AD...
https://eprints.whiterose.ac.uk/188700/1/eurosurv-27-26-4.pdf.  , 2022
 
?
 
?
6

Efficacy, safety and effect on gene expression profiling of..:

Quartier, P ; Allantaz, F ; Cimaz, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334078.  , 2008
 
?
8

Insights into systemic lupus erythematosus pathogenesis thr..:

Pascual, V ; Bennett, L ; Allantaz, F..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833510.  , 2004
 
?
10

Vous êtes des blagueurs / par un ouvrier, F. Allantaz:

Allantaz, F. Auteur du texte
Notice du catalogue : http://catalogue.bnf.fr/ark:/12148/cb30011032f.  , 1877
 
?
13

A point-prevalence study on community and inpatient Clostri..:

Viprey, Virginie F ; Davis, Georgina L ; Benson, Anthony D...
Viprey, Virginie F. Davis, Georgina L. Benson, Anthony D. Ewin, Duncan Spittal, William Vernon, Jon J. Rupnik, Maja Banz, Alice Allantaz, Florence Cleuziat, Philippe Novakova, Elena Matussek, Andreas Albert Fitzpatrick, Fidelma Simon, Anne Macovei, Ioana Barbut, Frederic Ramirez, Elena Reigadas Petinaki, Efi Kuijper, Ed J. Petrosillo, Nicola Pituch, Hanna Wilcox, Mark H. Davies, Kerrie A. . A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Eurosurveillance. 2022, 27(26).  , 2023
 
?
15

Expression profiling of human immune cell subsets identifie..:

Florence Allantaz ; Donavan T Cheng ; Tobias Bergauer...
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22276136/pdf/?tool=EBI.  , 2012
 
1-15